- Home
- CDTX vs GLV Comparison
CDTX vs GLV Comparison
Compare CDTX & GLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- GLV
- Stock Information
- Founded
- CDTX 2012
- GLV 2004
- Country
- CDTX United States
- GLV United States
- Employees
- CDTX N/A
- GLV N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- GLV Finance/Investors Services
- Sector
- CDTX Health Care
- GLV Finance
- Exchange
- CDTX Nasdaq
- GLV Nasdaq
- Market Cap
- CDTX 79.3M
- GLV 72.1M
- IPO Year
- CDTX 2015
- GLV N/A
- Fundamental
- Price
- CDTX $14.37
- GLV $5.68
- Analyst Decision
- CDTX Strong Buy
- GLV
- Analyst Count
- CDTX 5
- GLV 0
- Target Price
- CDTX $30.50
- GLV N/A
- AVG Volume (30 Days)
- CDTX 21.1K
- GLV 54.2K
- Earning Date
- CDTX 11-07-2024
- GLV 01-01-0001
- Dividend Yield
- CDTX N/A
- GLV 12.44%
- EPS Growth
- CDTX N/A
- GLV N/A
- EPS
- CDTX N/A
- GLV N/A
- Revenue
- CDTX $44,653,000.00
- GLV N/A
- Revenue This Year
- CDTX N/A
- GLV N/A
- Revenue Next Year
- CDTX N/A
- GLV N/A
- P/E Ratio
- CDTX N/A
- GLV N/A
- Revenue Growth
- CDTX 19.60
- GLV N/A
- 52 Week Low
- CDTX $10.00
- GLV $4.70
- 52 Week High
- CDTX $24.40
- GLV $6.06
- Technical
- Relative Strength Index (RSI)
- CDTX 72.85
- GLV 38.09
- Support Level
- CDTX $12.89
- GLV $5.78
- Resistance Level
- CDTX $13.78
- GLV $5.99
- Average True Range (ATR)
- CDTX 0.70
- GLV 0.14
- MACD
- CDTX 0.13
- GLV -0.01
- Stochastic Oscillator
- CDTX 75.31
- GLV 35.42
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About GLV Clough Global Dividend and Income Fund of beneficial interest
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.